Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine
Conditions: Migraine With Aura; Migraine Without Aura Interventions: Drug: Diclofenac Potassium 50Mg/Pkt Oral Pwdr; Drug: Rimegepant 75 MG Sponsor: Danish Headache Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium
Condition: Hypopituitarism Interventions: Drug: Intravenous Infusion of Diclofenac Sodium; Drug: Intravenous Infusion of Placebo Sponsor: Azienda Ospedaliera Città della Salute e della Scienza di Torino Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2022 Category: Research Source Type: clinical trials